tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jay Olson, 370 are a BUY (92.73%), 27 are a HOLD (6.77%), 2 are a SELL (0.5%).
Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 49.79% that have a potential upside of 44.35% achieved within 192 days.
Jay Olson’s has documented 860 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 06-Feb-2026.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 11/7/2019. The price target of $300 was fulfilled within 1 day with a profit of $19.5 (6.95%) receiving and performance score of 69.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Jun-2025
$30
$5.44 (22.15%)
$31
3 days ago
(26-Feb-2026)
0/6 (0%)
$5.03 (20.14%)
Buy Since 07-Aug-2015
$37
$12.44 (50.65%)
$35
3 days ago
(26-Feb-2026)
7/16 (43.75%)
$12.03 (48.18%)
671
Hold Since 03-Nov-2022
$24
$-0.56 (-2.28%)
$25
3 days ago
(26-Feb-2026)
18/22 (81.82%)
$-0.97 (-3.88%)
118
Hold Since 08-Oct-2025
$35
$10.44 (42.51%)
$29
6 days ago
(23-Feb-2026)
1/3 (33.33%)
$11.01 (45.89%)
35
Hold Since 09-May-2024
$35
$10.44 (42.51%)
$29
6 days ago
(23-Feb-2026)
11/16 (68.75%)
$11.01 (45.89%)
158
Which stock is Jay Olson is most bullish on?
Which stock is Jay Olson is most reserved on?
What Year was the first public recommendation made by Jay Olson?
